A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
RecruitingNCT05530655
University of RochesterProstate Cancer, Radiation Toxicity, Urinary Complication
Start: 2024-02-20End: 2028-01-01Target: 30Updated: 2026-07-23